Ozempic may have revealed the brain’s hidden “craving center”
For many people, the thought of a tasty burger or a cold pint of beer conjures up a vivid mental image and drives behavior. This link between thinking and doing…
AI helps Stanford scientists discover “natural Ozempic” without the usual side effects
Stanford Medicine researchers have identified a naturally occurring molecule that may suppress appetite and reduce body weight in a way that resembles semaglutide, the active ingredient in Ozempic. In animal…
The Ozempic and Wegovy mistake sending thousands to poison control
The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers’ attention: a…
Ozempic and Wegovy linked to surprising drop in violent behavior
Popular GLP-1 medications such as Ozempic and Wegovy are best known for helping people lose weight and manage diabetes. New research from Rutgers University suggests these drugs may also be…
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Popular medications such as Ozempic, Wegovy, Mounjaro, and Zepbound may offer an unexpected benefit beyond helping people lose weight and manage diabetes. New research involving more than 110,000 women found…
Scientists discover why ozempic may not work for some people
More than one-quarter of people with Type 2 diabetes now use GLP-1 receptor agonists, a class of medications that includes Ozempic. But new research from Stanford Medicine and international collaborators…
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
Researchers at the National Institutes of Health (NIH) have uncovered new details about how GLP-1 weight loss drugs such as semaglutide affect brain cells, revealing internal signaling processes that scientists…
Weight loss drug Ozempic linked to lower depression and anxiety risk
Medications used to treat type 2 diabetes and obesity, including well-known brands like Ozempic and Wegovy, may offer unexpected mental health benefits. These drugs belong to a class called GLP-1…
Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason
More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from Stanford Medicine and international collaborators suggests…
Weight loss drug Ozempic cuts depression, anxiety, and addiction risk
GLP-1 medications, such as semaglutide (Ozempic, Wegovy, and Rybelsus), commonly prescribed for diabetes and obesity may also be linked to better mental health outcomes, according to new research. The study…